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A 48 years old male presented to clinic with 12 months of low grade fever with shortness of breath which
has progressively worsened with no associated weight loss, night sweats or loss of appetite. There was no
prior history of chronic illness before the current illness. Laboratory workup revealed a high white blood
cell count with predominant eosinophils. Chest X-ray was normal. Transthoracic echocardiography and
Cardiac Magnetic Resonance showed biventricular thrombi. On further extensive workup the ﬁndings
were consistent with hypereosinophilic syndrome. The patient was started on oral steroids, hydroxyurea,
imatanib mesylate and oral anticoagulation. The patient responded to the treatment with complete
resolution of his symptoms over the course of few months. The repeat Echocardiogram after a year
showed normal left ventricular systolic and diastolic function with complete resolution of biventricular
thrombi.
Copyright © 2016 The Emergency Medicine Association of Turkey. Production and hosting by Elsevier
B.V. on behalf of the Owner. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Idiopathic hypereosinophilic syndrome (HES) is a rare hetero-
geneous leukoproliferative disorder with unexplained hypreosi-
nophilia andmulti-organ system dysfunction.1 The main diagnostic
criteria for HES include (1) hypereosinophilia-persistence of 1500
eosinophils/uL lasting > 6months, (2) no evidence of allergic,
parasitic, or other cause associated with hypereosinophilia, and (3)
evidence of organ damage (nervous system, lungs, heart, or bone
marrow).2 We are presenting a ﬁrst ever reported case of idiopathic
hypereosinophilic syndrome from Pakistan with biventricular api-
cal thrombus conﬁrmed with echocardiography and cardiac mag-
netic resonance. Our case is unique because of the unusual
presentation of the thrombus with idiopathic hypereosinophilic
syndrome. Also this is the ﬁrst case which is reported from
Pakistan, we have excluded all the major differentials of hyper-
eosinophilia. Our patient responded to oral steroids, imatinib
mesylate and hydroxyurea for eosinophilia and ACE inhibitor for0 Karachi, Pakistan. Tel.: þ92
heed).
ncy Medicine Association of
e Association of Turkey. Production
ons.org/licenses/by-nc-nd/4.0/).left ventricular diastolic dysfunction. The patient was followed
regularly for 1 year with full recovery of symptoms, normalization
of left ventricular diastolic dysfunction and persistance of biven-
tricular thrombi.
2. Case presentation
A 48 years-old male with no prior chronic illnesses presented to
out-patient department of our hospital with complaint of lowgrade
fever and shortness of breath for 12 months with no associated
night sweats, weight loss or loss of appetite. There was no history of
travel or contact with the sick. On examination the patient was
hemodynamically stable. Chest was clear with normal vesicular
breathing, cardiovascular examination was unremarkable,
abdomen was soft with no visceromegaly, Central nervous system
examination was normal and there was no lymph node palpable.
Because of his chronic illness which was progressing he was
admitted to hospital for workup.
3. Investigations
Initial work up revealed high WBC (22  109/L) count with pre-
dominant Eosinophils of 43%.Hemoglobin andplateletswerewithin
normal limits. ESR was 53 mm/h. Chest x-ray was negative for pul-
monary edema, inﬁltrates or ﬁbrotic changes. We consideredand hosting by Elsevier B.V. on behalf of the Owner. This is an open access article
Fig. 2. CMR, showing endomyocardial ﬁbrosis and LV apical thrombus.
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churg-strauss syndrome, malignancies and Hypereosinophilic syn-
drome as differential diagnoses to explain this eosinophilia. There
were no parasitic eggs or larvae in his stool and results of sera anti-
Aspergillus antibody tests were negative (to exclude parasitic
infection). Spirometrywas negative for anyobstructive or restrictive
lung pathology. Computed tomography (CT) scan detected no ab-
normalities in the lungs (eosinophilic pneumonia was excluded)
liver, gall bladder, pancreas and kidneys. Among six diagnostic
criteria for churg-strauss syndrome (CSS), only eosinophilia was
fulﬁlled. In addition, tests for anti-neutrophil cytoplasmic anti-
bodies (ANCAs) were negative. Therefore, CSS was unlikely. Tumor
markers were measured, carcinoembryonic antigen (CEA), Squa-
mous cell carcinoma (SCC), a-fetoprotein (AFP) were all negative.
Echocardiography (ECHO) was done to rule out any possible causes
of shortness of breath in this patient, ECHO revealed normal left
ventricular systolic function but with Grade II left ventricular dia-
stolic dysfunction and no valvular pathology (Fig. 1). ECHO also
revealed echogenic densities in right and left ventricular apices,
those were consistent with apical thrombi. Due to these ﬁndings
cardiac Magnetic resonance imaging (CMRI) was done to conﬁrm
the echo ﬁndings, CMRI showed normal left ventricular volumes
with normal left ventricular systolic function, a thin rim of left
ventricular apical thrombus and ﬁndings on late gadolinium images
were consistent with the diagnosis of endomyocardial ﬁbrosis sec-
ondary to HES (Fig. 2). Further evaluation of eosinophilia including.
FIP1-like 1/platelet-derived growth factor receptor a (FIP1L1-
PDGFRA) fusion gene test was positive. Bone marrow biopsy was
done which was positive for marked eosinophilia with hyper-
cellular bone marrow exhibiting markedly increased Eosinophils.
Based on these results, HES was diagnosed.
4. Treatment
Patients with symptomatic hypereosinophilia should be
managed emergently with high doses of glucocorticoids; an initial
dose of 1 mg/kg/day for a total duration of 1e2 weeks, then tapered
down to the lowest effective dose that maintains remission.3e5
Patients with positive FIP1L1/PDGFRA fusion gene should be
treated more aggressively with imatinib mesylate.4,6,7 The patient
was started on oral steroid and hydroxyurea and imatinib mesylate
for eosinophilia, along with ACE inhibitor for left ventricular dia-
stolic dysfunction and oral anticoagulation for apical thrombi, and
PT/INR was kept in the range of 2e3.
5. Outcome and follow up
The Patient was followed regularly in out-patient department
for symptoms, eosinophil counts and echocardiography for oneFig. 1. Transthoracic ECHO, showinyear. He has no fever and shortness of breath now and repeat ECHO
showed normal left ventricular systolic as well as diastolic function,
with complete resolution of thrombi from both apices and lastWBC
count is (8  109/L) with Eosinophil of 0.9%. Hemoglobin and
platelets are within normal limits.6. Discussion
HES is a disorder seen in young tomiddle-age patients. It is more
common in men compared to women.3,8e10 The disease is charac-
terized by unexplained hypereosinophilia that can involve different
organ systems. Cardiac involvement is found in about 60% of pa-
tients and is the predominant cause of morbidity and mortality in
this syndrome.11 This case is signiﬁcant because it fulﬁlls all of the
main criteria of HES, with bilateral ventricular apical thrombus and
ﬁbrotic changes. In the present case report wewill be discussing on
three points.
First, the echocardiography ﬁndings are the obliteration of the
apex of the left or right ventricle, or both by the laminar thrombus,
and the endomyocardial ﬁbrosis in the late ﬁbrotic stage of the
cardiac involvement. HES most commonly involves the posterior
wall of the left ventricle, posterior mitral valve leaﬂet resulting in
mitral regurgitation and involvement of the papillary muscles.12
The echocardiographic ﬁndings in our case revealed normal left
ventricular systolic function but with grade II left ventricular dia-
stolic dysfunction and no valvular pathologies. It also revealed
echogenic densities in right and left ventricular apices that were
consistent with apical thrombi. The posterior mitral leaﬂet was not
involved and also there was no involvement of the papillary
muscles.g large thrombi in ventricles.
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done to conﬁrm our echo ﬁndings which were consistent with the
echocardiography ﬁndings of normal ventricular volumes and
normal left ventricular systolic function. On late gadolinium images
a thin rim of left ventricular apical thrombus was appreciated in
concordance with the diagnosis of endomyocardial ﬁbrosis. The
ﬁndings of our CMRI did not show the diffuse circumferential
subendocardial high signal intensity in the midcavity and apical
segments after gadolinium contrast administration. Also there was
no acute myocardial edema with the same distribution of the
intracavitary thrombus at the right ventricle and left ventricle apex
which are consistent with high C- reactive protein levels in our
patient. The left ventricular cavity was also not dilated in our
patient.
Third, our patient was tested for the gene abnormality which
was positive. We started oral steroids, imatinib mesylate which is
the recommended therapy in FIPILI-PFGFRA positive patients.4,6,7
We started our patient oral anticoagulation with the aim of INR
in the range of 2e3. The ACE inhibitor was started for his left
ventricular dysfunction. On follow up our patient responded to the
above measures and the repeat echocardiogram demonstrated
normal left ventricular systolic and diastolic function with com-
plete resolution of the thrombus.Contributions
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